SlideShare a Scribd company logo
1 of 31
MONOCLONA
L
IN E.COLI
CONTENTS
• Basic concept and introduction.
• Advantages and disadvantages of using
monoclonal antibodies.
• Preparation of monoclonal antibodies.
• Applications of monoclonal antibodies.
MONOCLONAL IN E.COLI 2
BASIC CONCEPT AND INTRODUCTION
MONOCLONAL ANTIBODIES
WHAT ARE ANTIBODIES?
“ Every body has a specialized search and destroy army.
Antibodies are key players in that fight ”
Antibodies are protein made by plasma cells ( type of WBC’s) in
response to an antigen.
It is a Y shaped protein .
Every body naturally produces antibodies.
Are elements of the immune system produced by B lymphocytes.
Bind to foreign proteins in the body known as antigens, with the
aim of eliminating them.
Naturally circulate in the body searching for foreign bodies
(antigens).
MONOCLONAL IN E.COLI 4
MONOCLONAL IN E.COLI 5
Each tip of the “Y” of an antibody
contains a paratope (analogous to a
lock) that is specific for one particular
epitope (analogous to a key) on an
antigen, allowing these two structures
to bind together with precision.
They attach to the antigen and destroy
it by using various immune
mechanisms.
Classes- IgA, IgD, IgE, IgG, or IgM.
ANTIBODY
MONOCLONAL IN E.COLI 6
MONOCLONAL ANTIBODIES
Monoclonal: forming a clone which is derived asexually from a
single individual or cell.
Monoclonal antibodies are artificial antibodies that are produced
from a single clone of cells by fusing B lymphocytes to myeloma
cells.
The fusion of B-lymphocytes with myeloma cells by somatic cell
hybridization secretes desired antibody-producing elements which
are immortalized cell-lines known as a hybridoma.
These hybridomas produce homogenous monoclonal antibodies.
MONOCLONAL IN E.COLI 7
MONOCLONAL IN E.COLI 8
Monoclonal antibodies (mAbs) have the ability to recognize unique
binding sites (epitopes) found on the specific antigens.
This differentiates monoclonal antibodies from polyclonal
antibodies i.e. monoclonal antibodies are derived from a single B-
cell clone to target single epitopes, unlike polyclonal antibodies
that target multiple epitopes.
Monoclonal antibodies (mAbs) have been produced to target
receptors or other foreign proteins that are present on the surface
of normal cells and cancer cells.
MONOCLONAL ANTIBODIES
MONOCLONAL IN E.COLI 9
TYPES OF MONOCLONAL ANTIBODIES
Accordingly, mAbs are of four broad types.
Murine: Made from mouse proteins, names of drugs based on this end in –
omab.
Chimeric: A combination of mouse and human proteins, names of drugs
based on this end in –ximab.
Humanized: Here small doses of mouse proteins are attached to human
proteins, names of drugs based on this end in –zumab.
Human: These are fully human proteins, names of drugs based on this end in
–umab.
MONOCLONAL IN E.COLI 10
ADVANTAGES AND DISADVANTAGES
MONOCLONAL ANTIBODIES
ADVANTAGES OF USING MONOCLONAL ANTIBODIES
Monoclonal antibodies are one of the most successful
biotherapeutic drugs used in the treatment of many types of
cancer and autoimmune conditions.
They are also proven to reduce side-effects and improve patient
survival and well-being.
 As side effects can be treated and reduced by using mice-human
hybrid cells or by using fractions of antibodies.
It is highly scalable, unlimited production source
It can produce antibodies when needed.
Antigen or immunogen need not be pure.
MONOCLONAL IN E.COLI 12
DISADVANTAGES OF USING MONOCLONAL ANTIBODIES
It is a time consuming project, it may take time between 6 months
to 9 months.
It is very expensive.
It needs considerable effort to produce them.
System is only well developed for mouse and rat and not for other
animals.
More than 99% of the cells do not survive during the fusion
process that reduces the range of useful antibodies that can be
produced against an antigen.
There is also a possibility of generating immunogenicity (the ability
of a molecule or substance to provoke an immune response).
MONOCLONAL IN E.COLI 13
PREPARATION
MONOCLONAL ANTIBODIES
STEPS IN PRODUCTION OF MONOCLONAL ANTIBODIES
MONOCLONAL IN E.COLI 15
Step 1-Immunization of rabbit or rat and extraction of B-
lymphocytes
 In order to isolate B-lymphocyte producing certain antibodies,
rabbit or lab rat is immunized through repeated injection of
specific antigen (sheep RBCs)
 A sample of B-cells is extracted from spleen of rabbit or rat.
MONOCLONAL IN E.COLI 16
Step 2- Fusion of myeloma cell with B- Lymphocytes
• The extracted B-lymphocytes is added to a culture of myeloma cell from bone
marrow.
Multiple myeloma cells are abnormal plasma cells (a type of white blood cell)
that build up in the bone marrow and form tumors in many bones of the body.
• Hybridoma cells formed by fusion of B-cell and myeloma cell.
• The fusion is done by using Polyethylene glycol (PEG) or by electroporation or
by using phages.
MONOCLONAL IN E.COLI 17
Step 3- Selection of hybridoma cell
The B-lymphocytes contains HPRT1 gene which codes for enzyme
Hypoxanthine-guanine phosphoribosyltransferase (HGPRT).
(HGPRT) is one of the central enzymes that recycle the building blocks of RNA and DNA
B- cells can grow in medium containing Hypoxanthine amonopterin thymine
(HAT media).
HAT Medium is a selection medium for mammalian cell culture.
Myeloma cell lack HPRT1 gene so, it does not produce HGPTR enzyme and it
does not grow in HAT medium.
The myeloma cell do not utilize Hypoxanthine.
Only hybridoma cell i.e.. fused cell between myeloma and B-cell can
survive and divide in HAT medium.
Screening is done to select hybridoma cells which are the desired cell for
monoclonal antibodies production
MONOCLONAL IN E.COLI 18
Step 4- Culture of Hybridoma cell.
The selected hybridoma cells are cultured in suitable medium like insulin,
transferon, ethanol, amine and other additional hormones.
Some commonly used culture media for hybridoma cell for production of
monoclonal antibodies are:
• DMEM (Dulbecco’s modified eagle medium)
• IMDM (Iscove’s Modified Dulbecco’s Medium)
• Ham’s F12
• RPMI 1640 medium (Roswell Park Memorial Institute
• 1640 medium)
MONOCLONAL IN E.COLI 19
Step 5-Inoculation of hybridoma cell into suitable host.
These hybridoma cells are then injected into lab animal so that they starts
to produce monoclonal antibodies.
These hybridoma cells may be frozen and store for future use.
MONOCLONAL IN E.COLI 20
Step 6-Extraction and purification of Monoclonal antibodies.
Monoclonal antibodies from host animal can be extracted and purified by the
following methods:
Ion exchange chromatography
Antigen affinity chromatography
Radial immunoassay
Immune precipitation
MONOCLONAL IN E.COLI 21
MONOCLONAL ANTIBODIES IN E.COLI
MONOCLONAL IN E.COLI 23
Escherichia coli
 Escherichia coli, also known as E. coli, is a Gram-negative,
facultative anaerobic, rod-shaped bacteria.
 It is commonly found in the animal feces, lower intestines
of mammals, and even on the edge of hot springs.
 The simplicity and ease of fermentation has made E. coli
an ideal host for antibody fragment production.
 E. coli advantages include:
• Well characterized genetics
• Short process development timeline
• Simple fermentation
• Scalability
• Less safety issues from viral contaminants
MONOCLONAL ANTIBODIES IN E.COLI
MONOCLONAL IN E.COLI 24
There are situations where E. coli may become the preferred production host
over the presently used mammalian cells.
A monoclonal antibody (mAb) was obtained from a mouse immunized with
solubilized outer membrane proteins extracted from a bovine
enterohemorrhagic strain of Escherichia coli (EHEC), O26.
EHEC is a pathogenic group of strains.
MONOCLONAL IN E.COLI 25
 The mAb produced a strong immunoblot reaction
for E.coli 026.
 This mAb was used in a sandwich enzyme-linked
immunosorbent assay (ELISA) format to screen
strains from animal and human sources, and all
reactive strains.
 The antigen was detected in a group of strains
containing a high proportion of O26.
 The association of the antigen detected by the MAb
with significant enteropathogenic E. coli and EHEC
virulence factors in isolates from both animal and
human enteric infections indicates a diagnostic
potential for the assay developed.
MONOCLONAL IN E.COLI 26
OBJECTIVE
 The object was to produce monoclonal antibodies (mAbs) to EHEC surface
adhesion antigens, and to investigate their diagnostic application for the
detection of EHEC in animal and human enteric infections.
APPLICATIONS
MONOCLONAL ANTIBODIES
Disease diagnosis
• ELISA to test HIV, hepatitis, Herpes etc.
• RIA- to test viral infection.
• MAbs to Human chorionic gonadotropin.
Passive immunization or disease prevention
• Monoclonal antibodies based drugs can be used
to treat septic shock
• Used as vaccine
Detection and purification of biomolecules
• MAbs are very useful in determining the presence
and absence of specific proteins through western
blotting technique.
• Besides that, it can be used to classify strains of a
single pathogen. E.g. Neisseria gonorrhea can be
typed using Monoclonal antibodies.
MONOCLONAL IN E.COLI 28
SIDE-EFFECTS OF MONOCLONAL ANTIBODIES
MONOCLONAL IN E.COLI 29
Several monoclonal antibodies, such as bevacizumab and
cetuximab, can cause different kinds of side effects.
These side effects can be categorized into common and serious
side effects.
Common side effects include:
• Dizziness
• Headaches
• Allergies
• Fever
• Itching
• Insomnia
• Constipation etc.
30
Serious side effects are
• Anaphylaxis
• Bleeding
• Arterial and venous blood clots
• Autoimmune thyroiditis
• Hypothyroidism
• Hepatitis
• Heart failure
• Cancer
PRESENTED BY
Thank You
Kashish Imran
-Basic concept and
introduction
 Sadqua Urooj
-Advantages and
disadvantages of using
monoclonal antibodies.
 Khadeeja Yasmeen
-Preparation of monoclonal
antibodies
 Draksha
-Applications of monoclonal
antibodies.
MONOCLONAL IN E.COLI 31
-BSc Biotechnology, Sem II
PRESENTED TO
Dr. Saima Wajid|Professor
(Assistant)|Jamia Hamdard

More Related Content

Similar to Monoclonal antibodies in e.coli

monoclonal antibodies
monoclonal antibodiesmonoclonal antibodies
monoclonal antibodies
Nasa Ahmad
 

Similar to Monoclonal antibodies in e.coli (20)

MONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdfMONOCLONAL ANTIBODY.pdf
MONOCLONAL ANTIBODY.pdf
 
MCAB
MCABMCAB
MCAB
 
monoclonal antibodies
monoclonal antibodiesmonoclonal antibodies
monoclonal antibodies
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Monoclonal Antibodies
Monoclonal Antibodies Monoclonal Antibodies
Monoclonal Antibodies
 
Monoclonal antibody immunology
Monoclonal antibody immunologyMonoclonal antibody immunology
Monoclonal antibody immunology
 
Monoclonal vs Polyclonal antibodies
Monoclonal vs Polyclonal antibodiesMonoclonal vs Polyclonal antibodies
Monoclonal vs Polyclonal antibodies
 
Monoclonal antibodies explanation .pptx
Monoclonal antibodies explanation  .pptxMonoclonal antibodies explanation  .pptx
Monoclonal antibodies explanation .pptx
 
Monoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technologyMonoclonal antibody production by hybridoma technology
Monoclonal antibody production by hybridoma technology
 
Antibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptxAntibodies (Theraputic Protein) 2013.pptx
Antibodies (Theraputic Protein) 2013.pptx
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
monoclonal antibodies.pptx
monoclonal antibodies.pptxmonoclonal antibodies.pptx
monoclonal antibodies.pptx
 
Polyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody productionPolyclonal and monoclonal antibody production
Polyclonal and monoclonal antibody production
 
monoclonalantibodies.pdf
monoclonalantibodies.pdfmonoclonalantibodies.pdf
monoclonalantibodies.pdf
 
Monoclonal antibodies
Monoclonal antibodiesMonoclonal antibodies
Monoclonal antibodies
 
Project Report on Monoclonal antibodies By Vanshika
Project Report on Monoclonal antibodies By VanshikaProject Report on Monoclonal antibodies By Vanshika
Project Report on Monoclonal antibodies By Vanshika
 
Monoclonal Antibody production
Monoclonal Antibody productionMonoclonal Antibody production
Monoclonal Antibody production
 
Hybridoma technology
Hybridoma technologyHybridoma technology
Hybridoma technology
 
Monoclonal antibodies.ppt
Monoclonal antibodies.pptMonoclonal antibodies.ppt
Monoclonal antibodies.ppt
 
mono clonals.pptx
mono clonals.pptxmono clonals.pptx
mono clonals.pptx
 

Recently uploaded

1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
QucHHunhnh
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
MateoGardella
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
kauryashika82
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
MateoGardella
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
ciinovamais
 

Recently uploaded (20)

fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Measures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and ModeMeasures of Central Tendency: Mean, Median and Mode
Measures of Central Tendency: Mean, Median and Mode
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17Advanced Views - Calendar View in Odoo 17
Advanced Views - Calendar View in Odoo 17
 
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
Gardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch LetterGardella_PRCampaignConclusion Pitch Letter
Gardella_PRCampaignConclusion Pitch Letter
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Activity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdfActivity 01 - Artificial Culture (1).pdf
Activity 01 - Artificial Culture (1).pdf
 

Monoclonal antibodies in e.coli

  • 2. CONTENTS • Basic concept and introduction. • Advantages and disadvantages of using monoclonal antibodies. • Preparation of monoclonal antibodies. • Applications of monoclonal antibodies. MONOCLONAL IN E.COLI 2
  • 3. BASIC CONCEPT AND INTRODUCTION MONOCLONAL ANTIBODIES
  • 4. WHAT ARE ANTIBODIES? “ Every body has a specialized search and destroy army. Antibodies are key players in that fight ” Antibodies are protein made by plasma cells ( type of WBC’s) in response to an antigen. It is a Y shaped protein . Every body naturally produces antibodies. Are elements of the immune system produced by B lymphocytes. Bind to foreign proteins in the body known as antigens, with the aim of eliminating them. Naturally circulate in the body searching for foreign bodies (antigens). MONOCLONAL IN E.COLI 4
  • 5. MONOCLONAL IN E.COLI 5 Each tip of the “Y” of an antibody contains a paratope (analogous to a lock) that is specific for one particular epitope (analogous to a key) on an antigen, allowing these two structures to bind together with precision. They attach to the antigen and destroy it by using various immune mechanisms. Classes- IgA, IgD, IgE, IgG, or IgM.
  • 7. MONOCLONAL ANTIBODIES Monoclonal: forming a clone which is derived asexually from a single individual or cell. Monoclonal antibodies are artificial antibodies that are produced from a single clone of cells by fusing B lymphocytes to myeloma cells. The fusion of B-lymphocytes with myeloma cells by somatic cell hybridization secretes desired antibody-producing elements which are immortalized cell-lines known as a hybridoma. These hybridomas produce homogenous monoclonal antibodies. MONOCLONAL IN E.COLI 7
  • 8. MONOCLONAL IN E.COLI 8 Monoclonal antibodies (mAbs) have the ability to recognize unique binding sites (epitopes) found on the specific antigens. This differentiates monoclonal antibodies from polyclonal antibodies i.e. monoclonal antibodies are derived from a single B- cell clone to target single epitopes, unlike polyclonal antibodies that target multiple epitopes. Monoclonal antibodies (mAbs) have been produced to target receptors or other foreign proteins that are present on the surface of normal cells and cancer cells.
  • 10. TYPES OF MONOCLONAL ANTIBODIES Accordingly, mAbs are of four broad types. Murine: Made from mouse proteins, names of drugs based on this end in – omab. Chimeric: A combination of mouse and human proteins, names of drugs based on this end in –ximab. Humanized: Here small doses of mouse proteins are attached to human proteins, names of drugs based on this end in –zumab. Human: These are fully human proteins, names of drugs based on this end in –umab. MONOCLONAL IN E.COLI 10
  • 12. ADVANTAGES OF USING MONOCLONAL ANTIBODIES Monoclonal antibodies are one of the most successful biotherapeutic drugs used in the treatment of many types of cancer and autoimmune conditions. They are also proven to reduce side-effects and improve patient survival and well-being.  As side effects can be treated and reduced by using mice-human hybrid cells or by using fractions of antibodies. It is highly scalable, unlimited production source It can produce antibodies when needed. Antigen or immunogen need not be pure. MONOCLONAL IN E.COLI 12
  • 13. DISADVANTAGES OF USING MONOCLONAL ANTIBODIES It is a time consuming project, it may take time between 6 months to 9 months. It is very expensive. It needs considerable effort to produce them. System is only well developed for mouse and rat and not for other animals. More than 99% of the cells do not survive during the fusion process that reduces the range of useful antibodies that can be produced against an antigen. There is also a possibility of generating immunogenicity (the ability of a molecule or substance to provoke an immune response). MONOCLONAL IN E.COLI 13
  • 15. STEPS IN PRODUCTION OF MONOCLONAL ANTIBODIES MONOCLONAL IN E.COLI 15 Step 1-Immunization of rabbit or rat and extraction of B- lymphocytes  In order to isolate B-lymphocyte producing certain antibodies, rabbit or lab rat is immunized through repeated injection of specific antigen (sheep RBCs)  A sample of B-cells is extracted from spleen of rabbit or rat.
  • 16. MONOCLONAL IN E.COLI 16 Step 2- Fusion of myeloma cell with B- Lymphocytes • The extracted B-lymphocytes is added to a culture of myeloma cell from bone marrow. Multiple myeloma cells are abnormal plasma cells (a type of white blood cell) that build up in the bone marrow and form tumors in many bones of the body. • Hybridoma cells formed by fusion of B-cell and myeloma cell. • The fusion is done by using Polyethylene glycol (PEG) or by electroporation or by using phages.
  • 17. MONOCLONAL IN E.COLI 17 Step 3- Selection of hybridoma cell The B-lymphocytes contains HPRT1 gene which codes for enzyme Hypoxanthine-guanine phosphoribosyltransferase (HGPRT). (HGPRT) is one of the central enzymes that recycle the building blocks of RNA and DNA B- cells can grow in medium containing Hypoxanthine amonopterin thymine (HAT media). HAT Medium is a selection medium for mammalian cell culture. Myeloma cell lack HPRT1 gene so, it does not produce HGPTR enzyme and it does not grow in HAT medium. The myeloma cell do not utilize Hypoxanthine. Only hybridoma cell i.e.. fused cell between myeloma and B-cell can survive and divide in HAT medium. Screening is done to select hybridoma cells which are the desired cell for monoclonal antibodies production
  • 18. MONOCLONAL IN E.COLI 18 Step 4- Culture of Hybridoma cell. The selected hybridoma cells are cultured in suitable medium like insulin, transferon, ethanol, amine and other additional hormones. Some commonly used culture media for hybridoma cell for production of monoclonal antibodies are: • DMEM (Dulbecco’s modified eagle medium) • IMDM (Iscove’s Modified Dulbecco’s Medium) • Ham’s F12 • RPMI 1640 medium (Roswell Park Memorial Institute • 1640 medium)
  • 19. MONOCLONAL IN E.COLI 19 Step 5-Inoculation of hybridoma cell into suitable host. These hybridoma cells are then injected into lab animal so that they starts to produce monoclonal antibodies. These hybridoma cells may be frozen and store for future use.
  • 20. MONOCLONAL IN E.COLI 20 Step 6-Extraction and purification of Monoclonal antibodies. Monoclonal antibodies from host animal can be extracted and purified by the following methods: Ion exchange chromatography Antigen affinity chromatography Radial immunoassay Immune precipitation
  • 23. MONOCLONAL IN E.COLI 23 Escherichia coli  Escherichia coli, also known as E. coli, is a Gram-negative, facultative anaerobic, rod-shaped bacteria.  It is commonly found in the animal feces, lower intestines of mammals, and even on the edge of hot springs.  The simplicity and ease of fermentation has made E. coli an ideal host for antibody fragment production.  E. coli advantages include: • Well characterized genetics • Short process development timeline • Simple fermentation • Scalability • Less safety issues from viral contaminants
  • 24. MONOCLONAL ANTIBODIES IN E.COLI MONOCLONAL IN E.COLI 24 There are situations where E. coli may become the preferred production host over the presently used mammalian cells. A monoclonal antibody (mAb) was obtained from a mouse immunized with solubilized outer membrane proteins extracted from a bovine enterohemorrhagic strain of Escherichia coli (EHEC), O26. EHEC is a pathogenic group of strains.
  • 25. MONOCLONAL IN E.COLI 25  The mAb produced a strong immunoblot reaction for E.coli 026.  This mAb was used in a sandwich enzyme-linked immunosorbent assay (ELISA) format to screen strains from animal and human sources, and all reactive strains.  The antigen was detected in a group of strains containing a high proportion of O26.  The association of the antigen detected by the MAb with significant enteropathogenic E. coli and EHEC virulence factors in isolates from both animal and human enteric infections indicates a diagnostic potential for the assay developed.
  • 26. MONOCLONAL IN E.COLI 26 OBJECTIVE  The object was to produce monoclonal antibodies (mAbs) to EHEC surface adhesion antigens, and to investigate their diagnostic application for the detection of EHEC in animal and human enteric infections.
  • 28. Disease diagnosis • ELISA to test HIV, hepatitis, Herpes etc. • RIA- to test viral infection. • MAbs to Human chorionic gonadotropin. Passive immunization or disease prevention • Monoclonal antibodies based drugs can be used to treat septic shock • Used as vaccine Detection and purification of biomolecules • MAbs are very useful in determining the presence and absence of specific proteins through western blotting technique. • Besides that, it can be used to classify strains of a single pathogen. E.g. Neisseria gonorrhea can be typed using Monoclonal antibodies. MONOCLONAL IN E.COLI 28
  • 29. SIDE-EFFECTS OF MONOCLONAL ANTIBODIES MONOCLONAL IN E.COLI 29 Several monoclonal antibodies, such as bevacizumab and cetuximab, can cause different kinds of side effects. These side effects can be categorized into common and serious side effects. Common side effects include: • Dizziness • Headaches • Allergies • Fever • Itching • Insomnia • Constipation etc.
  • 30. 30 Serious side effects are • Anaphylaxis • Bleeding • Arterial and venous blood clots • Autoimmune thyroiditis • Hypothyroidism • Hepatitis • Heart failure • Cancer
  • 31. PRESENTED BY Thank You Kashish Imran -Basic concept and introduction  Sadqua Urooj -Advantages and disadvantages of using monoclonal antibodies.  Khadeeja Yasmeen -Preparation of monoclonal antibodies  Draksha -Applications of monoclonal antibodies. MONOCLONAL IN E.COLI 31 -BSc Biotechnology, Sem II PRESENTED TO Dr. Saima Wajid|Professor (Assistant)|Jamia Hamdard